sutimlimab
sutimlimab is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: liquid.
Drug Details
- Generic Name
- sutimlimab
- Brand Names
- N/A
- Application Number
- Sponsor
- Biogen Inc.
- NDC Codes
- 1
- Dosage Forms
- LIQUID
- Routes
- N/A
- Active Ingredients
- SUTIMLIMAB
Indications and Usage
1 INDICATIONS AND USAGE ENJAYMO is a classical complement inhibitor indicated for the treatment of hemolysis in adults with cold agglutinin disease (CAD). ( 1 ) Cold Agglutinin Disease ENJAYMO (sutimlimab-jome) is indicated for the treatment of hemolysis in adults with cold agglutinin disease (CAD).